Cor Vasa 2019, 61(5):524-528 | DOI: 10.33678/cor.2019.031

Successful management of a child with Kawasaki disease complicated by acute myocardial infarction

Houssem Thabet, Nejeh Ben Halima, Ahmed Sghaier
Department of Cardiology, Ibn El jazzar Hospital Kairouan Tunisia, Faculty of Medicine, Souuse, Tunisia

Kawasaki disease presents as multisystemic acute vasculitis. This panvascularity essentially affects the arteries of medium caliber, with an elective tropism for the coronary arteries, whose attack makes all the gravity of the disease. Although early treatment with intravenous immunoglobulin reduces the risk of cardiovascular complications in Kawasaki disease, in refractory cases myocardial infarction can result from thrombosis of coronary artery aneurysms. This report describes successful management of myocardial infarction from coronary thrombosis in a 4-year-old infant with Kawasaki disease using intravenous Tenecteplase followed by percutaneous coronary intervention.

Keywords: Kawasaki, Myocardial infarction, Percutaneous treatment, Tenecteplase

Accepted: May 29, 2018; Published: October 20, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Thabet H, Halima NB, Sghaier A. Successful management of a child with Kawasaki disease complicated by acute myocardial infarction. Cor Vasa. 2019;61(5):524-528. doi: 10.33678/cor.2019.031.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation 2017;136:e927-e999. Go to original source... Go to PubMed...
    2. Kawasaki T. Acute febrile MCLNS. Clinical observations of 50 cases. Jpn J Allerg 1967;16:178-222.
    3. Yanagawa H, Nakamura Y, Yashiro M, et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 2001;107:E33. Go to original source... Go to PubMed...
    4. Holman RC, Curns AT, Belay ED, et al. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics 2003;112:495-501. Go to original source... Go to PubMed...
    5. Davis RL, Waller PL, Mueller BA, et al. Kawasaki syndrome in Washington State. Race-specific incidence rates and residential proximity to water. Arch Pediatr Adolesc Med 1995;149:66-69. Go to original source... Go to PubMed...
    6. Rauch AM, Hurwitz ES. Center for Disease Control (CDC) case definition for Kawasaki syndrome. Pediatr Infect Dis 1985;4:702-703.
    7. Mori M, Imagawa T, Yasui K, et al. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease. J Pediatr 2000;137:177-180. Go to original source... Go to PubMed...
    8. Davis RL, Waller PL, Mueller BA, et al. Kawasaki syndrome in Washington State. Race-specific incidence rates and residential proximity to water. Arch Pediatr Adolesc Med 1995;149:66-69. Go to original source... Go to PubMed...
    9. Hiraishi S, Misawa H, Takeda N, et al. Transthoracic ultrasonic visualisation of coronary aneurysm, stenosis, and occlusion in Kawasaki disease. Heart 2000;83:400-405. Go to original source... Go to PubMed...
    10. Capannari TE, Daniels SR, Meyer RA, et al. Sensitivity, specificity, and predictive value of two-dimensional echocardiography in detecting coronary artery aneurysms in patients with Kawasaki disease. J Am Coll Cardiol 1986;7:355-360. Go to original source... Go to PubMed...
    11. Newburger JW, Takahashi M, Gerber MA, et al. Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease; Council on Cardiovascular Disease in the Young; American Heart Association; American Academy of Pediatrics. Diagnosis, treatment, and longterm management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004;110:2747-2771. Go to original source... Go to PubMed...
    12. Sasaguri Y, Kato H. Regression of aneurisms in Kawasaki disease: a pathological study. J Pediatr 1982;100:225-231. Go to original source... Go to PubMed...
    13. Sugimura T, Kato H, Inoue O, et al. Intravascular ultrasoud of coronary arteries in children. Assessment of the wall morphology and the lumen after Kawasaki disease. Circulation 1994;89:258-265. Go to original source... Go to PubMed...
    14. Sohn S, Kim HS, Lee SW. Multidetector row computed tomography for follow-up of patients with coronaryartery aneurysms due to Kawasaki disease. Pediatr Cardiol 2004;25:35-39. Go to original source... Go to PubMed...
    15. Kato H, Ichinose E, Yoshioka F. Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. Am J Cardiol 1982;49:1758-1766. Go to original source... Go to PubMed...
    16. Tsuda E, Kamiya T, Kimura K, et al. Coronary artery dilatation exceeding 4.0 mm during acute Kawasaki disease predicts a high probability of subsequent late intima-medial thickening. Pediatr Cardiol 2002;23:9-14. Go to original source... Go to PubMed...
    17. Tsuda E, Kamiya T, Ono Y, et al. Incidence of stenotic lesions predicted by acute phase changes in coronary arterial diameter during Kawasaki disease. Pediatr Cardiol 2005;26:73-79. Go to original source... Go to PubMed...
    18. Hashino K, Ishii M, Iemura M, et al. Re-treatment for immuneglobulin resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int 2001;43:211-217. Go to original source... Go to PubMed...
    19. Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol 2012;22:79-85. Go to original source... Go to PubMed...
    20. Kato H, Ichinose E, Kawasaki T. Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases. J Pediatr 1986;108:923-927. Go to original source... Go to PubMed...
    21. Tsubata S, Ichida Fl, Hamamichi Y, et al. Successful thrombolytic therapy using tissuetype plasminogen activator in Kawasaki disease. Pediatr Cardiol 1995;16:186-189. Go to original source...
    22. Sohn S, Kwon K. Accelerated thrombotic occlusion of a medium-sized coronary aneurysm in Kawasaki disease by the inhibitory effect of ibuprofen on aspirin. Pediatr Cardiol 2008;29:153-156. Go to original source... Go to PubMed...
    23. Crystal MA. Thrombolytic Use in Children: Breaking Down Barriers. J Pediatr 2016;171:12-13. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes